Lpl Financial LLC Axogen, Inc. Transaction History

Lpl Financial LLC

$238 Billion
Q4 2024

A detailed history of Lpl Financial LLC transactions in Axogen, Inc. stock. As of the latest transaction made, Lpl Financial LLC holds 12,766 shares of AXGN stock, worth $226,213. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,766

Holding current value

$226,213

% of portfolio

0.0%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	BUY	$12.47 - $17.19 $159,192 - $219,447	12,766 New	12,766 $210,000
Q1 2020 May 14, 2020	SELL	$8.38 - $17.34 $104,800 - $216,854	-12,506 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$11.18 - $18.6 $2,727 - $4,538	244 Added 1.99%	12,506 $224,000
Q3 2019 Nov 13, 2019	BUY	$12.09 - $20.46 $148,247 - $250,880	12,262 New	12,262 $153,000
Q4 2018 Feb 07, 2019	SELL	$17.09 - $38.25 $164,781 - $368,806	-9,642 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$34.05 - $55.9 $95,918 - $157,470	-2,817 Reduced 22.61%	9,642 $355,000
Q2 2018 Aug 14, 2018	BUY	$36.15 - $52.5 $25,558 - $37,117	707 Added 6.02%	12,459 $626,000
Q1 2018 May 15, 2018	BUY	$24.4 - $40.25 $3,782 - $6,238	155 Added 1.34%	11,752 $429,000
Q4 2017 Feb 14, 2018	SELL	$18.5 - $28.6 $1,831 - $2,831	-99 Reduced 0.85%	11,597 $328,000
Q2 2017 Aug 14, 2017	BUY	N/A	11,696	11,696 $196,000

Others Institutions Holding AXGN

# of Institutions

176

Shares Held

36.6M

Call Options Held

230K

Put Options Held

400

First Light Asset Management, LLC Edina, MN

4.09M
Shares

$72.5 Million
5.0% of portfolio
Black Rock Inc. New York, NY

3.25M
Shares

$57.6 Million
0.0% of portfolio
Soleus Capital Management, L.P. Greenwich, CT

3.01M
Shares

$53.3 Million
3.58% of portfolio
Morgan Stanley New York, NY

2.9M
Shares

$51.4 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

2.43M
Shares

$43 Million
0.0% of portfolio

View Full List

About Axogen, Inc.

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $749M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

More about AXGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Account